000			01959 a2200589 4500
005			20250513214446.0
264		0	_c20000815
008			200008s 0 0 eng d
022			_a0028-3878
024	7		_a10.1212/wnl.55.2.185 _2doi
040			_aNLM _beng _cNLM
100	1		_aSimon, J H
245	0	0	_aA longitudinal study of T1 hypointense lesions in relapsing MS: MSCRG trial of interferon beta-1a. Multiple Sclerosis Collaborative Research Group. _h[electronic resource]
260			_bNeurology _cJul 2000
300			_a185-92 p. _bdigital
500			_aPublication Type: Clinical Trial; Clinical Trial, Phase III; Controlled Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdjuvants, Immunologic _xadverse effects
650	0	4	_aAdult
650	0	4	_aBrain _xdrug effects
650	0	4	_aDisease Progression
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aInjections, Intramuscular
650	0	4	_aInterferon beta-1a
650	0	4	_aInterferon-beta _xadverse effects
650	0	4	_aLongitudinal Studies
650	0	4	_aMagnetic Resonance Imaging
650	0	4	_aMale
650	0	4	_aMultiple Sclerosis, Relapsing-Remitting _xdiagnosis
700	1		_aLull, J
700	1		_aJacobs, L D
700	1		_aRudick, R A
700	1		_aCookfair, D L
700	1		_aHerndon, R M
700	1		_aRichert, J R
700	1		_aSalazar, A M
700	1		_aSheeder, J
700	1		_aMiller, D
700	1		_aMcCabe, K
700	1		_aSerra, A
700	1		_aCampion, M K
700	1		_aFischer, J S
700	1		_aGoodkin, D E
700	1		_aSimonian, N
700	1		_aLajaunie, M
700	1		_aWende, K
700	1		_aMartens-Davidson, A
700	1		_aKinkel, R P
700	1		_aMunschauer, F E
773	0		_tNeurology _gvol. 55 _gno. 2 _gp. 185-92
856	4	0	_uhttps://doi.org/10.1212/wnl.55.2.185 _zAvailable from publisher's website
999			_c10859047 _d10859047